Sulfanilamide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00259 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 11 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | postmenopausal atrophic vaginitis | KG + DL |
| 2 | ulceration of vulva | KG + DL |
| 3 | vulvar neoplasm | KG + DL |
| 4 | trichomonal vulvovaginitis | KG + DL |
| 5 | vaginal discharge | KG + DL |
| 6 | leukoplakia of vagina | KG + DL |
| 7 | blunt duct adenosis of breast | KG + DL |
| 8 | apocrine adenosis of breast | KG + DL |
| 9 | infective vaginitis | KG + DL |
| 10 | herpetic vulvovaginitis | KG + DL |
| 11 | breast fibrocystic disease | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.